title: Archimedes. Question 3. Should carbamazepine be administered to manage agitation and aggressive behaviour following paediatric acquired brain injury?
authors.affiliation: Paediatric Neuropsychology, The Leeds Teaching Hospitals NHS Trust, Leeds, UK.
authors.forename: Emma
authors.initials: E
authors.lastname: Waters
authors.forename: Matthew C H J
authors.initials: MC
authors.lastname: Morrall
authors.forename: Deborah
authors.initials: D
authors.lastname: Murdoch-Eaton
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000627:therapeutic use*; D001930:Brain Injuries / Q000150:complications*; D002220:Carbamazepine / Q000627:therapeutic use*; D002653:Child Behavior Disorders / Q000188:drug therapy* / Q000209:etiology; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine